BENEFITS OF ANTI-HYPERTENSIVE THERAPY IN THE ELDERLY

被引:6
|
作者
POTTER, JF
HAIGH, RA
机构
[1] Department of Medicine for the Elderly, University of Leicester, Leicester General Hospital, Leicester
关键词
D O I
10.1093/oxfordjournals.bmb.a072396
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension is common in the elderly, up to half of the population over the age of 65 years can be so classified. Raised systolic and diastolic blood pressure levels increase the risk of cardiovascular morbidity and mortality in those aged up to 80 years.Recent intervention studies have shown that anti-hypertensive treatment reduces death from stroke and myocardial infarction, without producing intolerable side-effects. The benefits of treating isolated systolic hypertension and hypertension following stroke are, as yet, unproven.The therapeutic goals for treating hypertension in the elderly should be to lower blood pressure while keeping adverse reactions to a minimum and thereby not impairing the patient's quality of life. Non-pharmacological methods should be tried initially before resorting to drug therapy. Both thiazide diuretics and beta-adrenoceptor antagonists are of proven value as first line hypotensive agents in the elderly. Drug therapy should be tailored to the individual patient and increased slowly to reduce the incidence of side-effects. © 1990 The British Council.
引用
收藏
页码:77 / 93
页数:17
相关论文
共 50 条
  • [1] Benefits of adherence to anti-hypertensive drug therapy
    Flack, JM
    Novikov, SV
    Ferrario, CM
    [J]. EUROPEAN HEART JOURNAL, 1996, 17 : 16 - 20
  • [2] ANTI-HYPERTENSIVE THERAPY IN THE ELDERLY AND ITS EFFECTS ON CEREBRAL FUNCTION
    MIDDLETON, RSW
    [J]. MECHANISMS OF AGEING AND DEVELOPMENT, 1984, 28 (2-3) : 229 - 236
  • [3] INFLUENCE OF ANTI-HYPERTENSIVE THERAPY ON SERUM-CHOLESTEROL IN ELDERLY HYPERTENSIVE PATIENTS
    AMERY, A
    BIRKENHAGER, W
    BULPITT, C
    CLEMENT, D
    DERUYTTERE, M
    DESCHAEPDRYVER, A
    DOLLERY, C
    FAGARD, R
    FORETTE, F
    FORTE, J
    HAMDY, R
    LEONETTI, G
    LUNDJOHANSEN, P
    MACFARLANE, JPR
    MUTSERS, A
    OMALLEY, K
    TUOMILEHTO, J
    [J]. ACTA CARDIOLOGICA, 1982, 37 (04) : 235 - 244
  • [4] Tailoring anti-hypertensive treatment in the elderly
    Bonapace, S
    Rajkumar, C
    Bulpitt, CJ
    [J]. JOURNAL OF HUMAN HYPERTENSION, 1998, 12 (09) : 615 - 620
  • [5] Tailoring anti-hypertensive treatment in the elderly
    S Bonapace
    C Rajkumar
    CJ Bulpitt
    [J]. Journal of Human Hypertension, 1998, 12 : 615 - 620
  • [6] The ABCD of anti-hypertensive therapy?
    Chalmers, J
    [J]. JOURNAL OF HYPERTENSION, 2002, 20 (04) : 615 - 616
  • [7] The Pharmacogenomics of Anti-Hypertensive Therapy
    Padmanabhan, Sandosh
    Paul, Laura
    Dominczak, Anna F.
    [J]. PHARMACEUTICALS, 2010, 3 (06) : 1779 - 1791
  • [8] ANTI-HYPERTENSIVE THERAPY ANALYSIS
    DOUGLAS, BH
    PARKS, BR
    RAWSON, JE
    [J]. CLINICAL AND EXPERIMENTAL HYPERTENSION PART B-HYPERTENSION IN PREGNANCY, 1984, 3 (2-3): : 450 - 450
  • [9] Tetrahydrobiopterin: A novel anti-hypertensive therapy
    Porkert, M
    Sher, S
    Reddy, U
    Cheema, F
    Niessner, C
    Kolm, P
    Jones, D
    Hooper, C
    Taylor, WR
    Harrison, D
    Quyyumi, AA
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 371A - 371A
  • [10] RENAL CONSEQUENCES OF ANTI-HYPERTENSIVE THERAPY
    REUBI, F
    [J]. JOURNAL D UROLOGIE ET DE NEPHROLOGIE, 1977, 83 (4-5): : 296 - 302